BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2013
View Archived Issues
Volasertib inferior to pemetrexed in phase II trial for NSCLC
Read More
Farletuzumab misses phase II endpoint for NSCLC
Read More
Small-molecule antagonists identified for the treatment of light-sensitive migraine
Read More
Isis Pharmaceuticals begins phase II trial of ISIS-GCCRRx in combination with metformin
Read More
RINT1 gene mutations linked to early-onset breast cancer
Read More
Phase I data for the GS-4774 vaccine confirm tolerability and immunogenicity
Read More
Otsuka and Lundbeck partner for nalmefene in Japan
Read More
CRT Pioneer Fund and Chroma form collaboration to develop anticancer drugs targeting macrophages
Read More
Mochida Pharmaceutical synthesizes novel FFA1 agonists
Read More
Fidelity Biosciences and ReGenX Biosciences launch new company
Read More
Achillion details development of hepatitis C virus candidate ACH-3422
Read More
New gamma-carbolines designed at IntraCellular Therapies
Read More
Chinese and U.S. team patents novel HD6 inhibitors
Read More
arGEN-X and de Duve Institute/UCL sign collaboration to develop immunomodulation therapy for cancer
Read More
Testing supports development of Pluristem's PLX cells for pre-eclampsia
Read More
Pfizer provides overview of third quarter 2013
Read More
Dainippon Sumitomo Pharma provides overview of second quarter of fiscal 2013
Read More
BioLineRx receives approval to begin trial of BL-7010 in celiac disease
Read More
Ampio Pharmaceuticals reports data from extension of SPRING study
Read More
Allegro Ophthalmics begins phase II study of ALG-1001 for vitreomacular traction
Read More
New IL-17 production inhibitors disclosed by Mitsubishi Tanabe Pharma
Read More
Almirall submits MAA in Europe for fixed-dose aclidinium and formoterol
Read More
LC-540449 demonstrates efficacy in a preclinical model of non-alcoholic steatohepatitis
Read More
Genkyotex begins multinational phase II study of NOX inhibitor
Read More
Actelion launches Opsumit for treatment of PAH in the U.S.
Read More
Thomson Reuters and NuMedii collaborate on drug repurposing initiative
Read More
AB Science to advance masitinib to phase III development for treatment of ALS
Read More